DACHAO
Latest round
- Series B
Last raised
- Aug 2023
Total raised
- Undisclosed
Investors
- 1
About DACHAO
Based in Beijing, China, and founded in 2021, DACHAO operates as a provider of assisted reproduction services, specializing in the innovative development of reproductive health and anti-aging products. The company has cooperated with Sun Yat-sen Hospital of Sun Yat-sen University, Beijing Chaoyang Hospital, and West China Second Hospital of Sichuan University.S. Food and Drug Administration (FDA), Food Safety Certification (HACCP), Good Manufacturing Practice Certification (GMP), and International Consumer Quality Certification (ISO). DACHAO's main products are Reco18, Reju28, PCOS, Dajin 1 and other series of reproductive nutritional supplements. The company's products can be used for hormone-free ovarian function regulation, seminal function regulation and polycystic syndrome and menopausal syndrome relief, etc.
Who invested in DACHAO
1 investor across 1 round
See all investors in DACHAO
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Aug 1, 2023
Amount
Undisclosed
Investors
Questions about DACHAO
Who invested in DACHAO?
DACHAO has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DACHAO raised?
DACHAO has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did DACHAO last raise money?
DACHAO's most recent round on record is a Series B, in Aug 2023.
What does DACHAO do?
Based in Beijing, China, and founded in 2021, DACHAO operates as a provider of assisted reproduction services, specializing in the innovative development of reproductive health and anti-aging products.
Where is DACHAO headquartered?
DACHAO is headquartered in Beijing, China.
Which VCs invest in companies like DACHAO?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at DACHAO's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like DACHAO? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.